William E. Dager, Pharm.D., BCPS (AQ-Cardiology), Activity Chair
UC Davis Medical Center
William E. Dager, Pharm.D., BCPS (AQ-Cardiology), is a pharmacist specialist at UC Davis Medical Center in Sacramento, California, where he is responsible for managing challenging cases in anticoagulation, pharmacokinetics, and critical care. He also is clinically active with the cardiology service and serves as the director of the postgraduate year two (PGY-2) residency in cardiology at UC Davis. In addition, Dr. Dager holds three academic positions. He is Clinical Professor of Pharmacy at the University of California, San Francisco (UCSF) School of Pharmacy and Clinical Professor of Medicine at the University of California, Davis (UC Davis) School of Medicine. He also serves as Clinical Professor at the Touro School of Pharmacy in Vallejo, California.
Dr. Dager earned his Doctor of Pharmacy degree at UCSF and completed a residency at the UC Davis Medical Center in Sacramento. In addition, he completed the University of Pittsburgh Nephrology Pharmaceutical Care Preceptorship. He is a board-certified pharmacotherapy specialist and fellow of the American College of Clinical Pharmacy (ACCP), American Society of Health-System Pharmacists (ASHP), California Society of Hospital Pharmacists, and Society of Critical Care Medicine (SCCM).
Dr. Dager's research interests focus on anticoagulation, critical care medicine, cardiovascular disease, and pharmacokinetics and pharmacodynamics. He has authored numerous articles, book chapters, and scientific reviews, and he coauthored "Anticoagulation Therapy: A Point-of-care Guide" published by ASHP in 2011. He also regularly makes presentations at national and international educational conferences. Dr. Dager serves as a reviewer and editorial board member for several medical journals, and he currently is chair of the Editorial Advisory Board Panel on Anticoagulation for The Annals of Pharmacotherapy. He has served as a site coordinator for the ASHP Research and Education Foundation Antithrombotic Pharmacotherapy Traineeship. Dr. Dager has received multiple teaching and professional awards, including the 2008 ACCP Best Practice Award.
Surabhi Palkimas, Pharm.D.
Pharmacy Clinical Coordinator, Hematology
University of Virginia Health System
Surabhi Palkimas, Pharm.D., is Pharmacy Clinical Coordinator in Hematology at University of Virginia (UVA) Health System in Charlottesville, Virginia. In this role, she provides pharmacy services for the adult hematology inpatient consult team. Dr. Palkimas also serves as pharmacy chair of the Anticoagulation Committee and is an active member of the Patient Education and Communication Committee. In addition, she is a preceptor for the postgraduate year one (PGY-1) pharmacy residency and postgraduate year two (PGY-2) oncology residency at UVA Health System, both of which are accredited by the American Society of Health-System Pharmacists (ASHP).
Dr. Palkimas earned a Bachelor of Science degree in biochemical pharmacology from State University of New York at Buffalo and a Doctor of Pharmacy degree from Massachusetts College of Pharmacy & Health Sciences, Worcester Campus. She completed an ASHP-accredited PGY-1 pharmacy practice residency at Hospital of Saint Raphael in New Haven, Connecticut.
Dr. Palkimas is a member of ASHP, American College of Clinical Pharmacy, Virginia Pharmacists Association, and Anticoagulation Forum. In addition, she serves as a peer reviewer for The Annals of Pharmacotherapy. In addition, she serves as a peer reviewer for The Annals of Pharmacotherapy.
Mark T. Reding, M.D.
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center, Fairview
University of Minnesota Medical School
Mark T. Reding, M.D., is Director of the Center for Bleeding and Clotting Disorders at University of Minnesota Medical Center in Minneapolis. In this role he is responsible for providing and coordinating patient care in the clinic and hospital for all adult patients followed by the Center, which is a hemophilia treatment center supported by the Centers for Disease Control and Prevention. Dr. Reding also serves as Medial Director of the Inpatient Hematology/Oncology Unit at University of Minnesota Medical Center. In addition, he is Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota.
Dr. Reding received his Bachelor of Science degree in microbiology and biology at South Dakota State University in Brookings. He then earned a Doctor of Medicine degree at University of Minnesota Medical School in Minneapolis. He is board certified in hematology.
Dr. Reding's clinical interest is the treatment of non-malignant hematologic disorders with particular emphasis on disorders of hemostasis and thrombosis, including hemophilia. His current research efforts focus on the immune response to factor VIII, the cellular mechanisms involved in the synthesis of factor VIII inhibitors, and the immunologic consequences of gene therapy. He has also served as the local principal investigator for multi-center clinical trials. His research has been published in peer-reviewed journals.
Dr. Reding considers teaching to be the most important and rewarding aspect of his work, and he twice was awarded the Outstanding Clinical Mentor Award from his division at the Medical School. In addition to teaching responsibilities at the University, he frequently speaks at educational programs for physicians and other health care professionals.
Dr. Reding is a member of American Society of Hematology, Hemostasis and Thrombosis Research Society (HTRS), and International Society for Thrombosis and Hemostasis. He recently completed a two-year term on the board of directors for HTRS.